Evidence map›Paper›PMID 32796262›Full record

ArticleJournal of lower genital tract disease2020

Patient Satisfaction With Human Papillomavirus Self-Sampling in a Cohort of Ethnically Diverse and Rural Women in Yunnan Province, China.

Andrew Goldstein, Benjamin Plafker, Sarah Stamper, Lena Goldstein, Roberta Lipson, Sarah Bedell, Jue Wang, Gal Brenner, Gail Goldstein, Karen O'Keefe and 5 more

Abstract read
In one paragraph

Article in Journal of lower genital tract disease, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. The Future of Cervical Cancer Screening.International journal of women's health · 2024
    Review
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Andrew GoldsteinCenters for Vulvovaginal Disease, Washington, DC.
Benjamin PlafkerUnited Family Hospitals, Beijing, China.
Sarah StamperJohns Hopkins University, Baltimore, MD.
Lena GoldsteinYale University, New Haven, CT.
Roberta LipsonUnited Family Hospitals, Beijing, China.
Sarah BedellCenters for Vulvovaginal Disease, New York, NY.
Jue WangUnited Family Hospitals, Beijing, China.
Gal BrennerMobileODT, Israel.
Gail GoldsteinAnnapolis Dermatology Center, Annapolis, MD.
Karen O'KeefeBellingham Bay Family Medicine, Bellingham, WA.
Casey O'KeefePacific Northwest Urology Specialists, Bellingham, WA.
McKenna O'KeefeUniversity of California, Berkeley, CA.
Tierney O'KeefeScripps College, Claremont, CA.
Amelia GoldsteinDuke University, Durham, NC.
Anna ZhaoUnited Family Hospitals, Beijing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveRural Yunnan Province is one of the most ethnically, culturally, and religiously diverse regions in China. The majority of its women have never been screened for cervical cancer. It is not known whether women would feel comfortable and ultimately even prefer using a human papillomavirus (HPV) self-swabbing method.

methodsIn a 6-day period, 3,600 women were taught the role of HPV in cervical cancer. They were then given self-swabbing instructions. After obtaining their specimens, 600 women were interviewed about their experience with HPV self-testing. The women were of the Yi, Hui, Dai, and Han ethnicities.

resultsThe overwhelming majority of the women surveyed understood the self-sampling instructions (588/600, 98%) and felt comfortable carrying out the self-sampling procedure (584/600, 97%). Significantly more women (389/600, 64.8%) preferred self-sampling to having the provider (211/600, 35.2%) obtain the sample (χ = 105.61, p < .05). Women who preferred self-sampling did so primarily because they felt capable of obtaining the specimens (n = 80) or that it was a more convenient way to be tested (n = 79). The medical expertise of the provider (n = 74) and concerns over the accuracy of the test (n = 88) shifted some women's preference toward a provider-obtained sample.

conclusionsThere are 400+ million Chinese women who have never had a cervical cancer screening. Self-testing has the potential to significantly increase the number of women tested. Despite the diversity of the women screened, the majority felt comfortable self-sampling and preferred self-swabbing to provider testing.

Indexed as

Patient Acceptance of Health CarePatient SatisfactionSelf-TestingChinaCohort StudiesFemaleHumansPapillomaviridaePapillomavirus InfectionsPatient Education as TopicRural Population

Identifiers

PMID32796262
PMCPMC7515469

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.